Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat in Relapsed or Refractory Hodgkin's Lymphoma
NCT00866333Phase 2Terminated
- Sponsor
- Syndax Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in Hodgkin lymphoma (HL), sponsored by Syndax Pharmaceuticals. Started Apr 2009; status: terminated.
02
Drugs
entinostat
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00866333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866333.